Back to search

Ireland· IE-PA-PA23148/010/001

Methenamine hippurate Brown & Burk 1 g tablets

A methenamine product containing methenamine hippurate, registered in Ireland by Brown & Burk IR Limited. The same ATC class is registered in 9 of our 19 countries.

ATC J01XX05

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedMethenamine hippurate Brown & Burk 1 …ATCJ01XX05REGISTER NO.IE-PA-PA23148/010/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Methenamine is registered in 9 of 19 countries.

Countries holding a registration under ATC J01XX05 (methenamine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Methenamine · ATC J01XX05

9 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Methenamine hippurate
Manufacturer
Brown & Burk IR Limited
Country
Ireland (IE)
ATC code
J01XX05
ATC class
Methenamine
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA23148/010/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

22 interactions on record for methenamine.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Methenamine · interactions on record

22 records

  • 4 severe
  • 18 moderate

Most severe, free to view

  • SulfasalazineA07EC01severe
  • SulfamethizoleB05CA04severe
  • SulfamethizoleJ01EB02severe
  • SulfasalazinM01CX02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Methenamine in 6 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All methenamine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Belgium · Vesaphir
  • Germany · Cystohipp
  • Denmark · Haiprex, Methenamine Hippurate Eql Pharma
  • Finland · Hiprex, Methenamine Hippurate Orion
  • France · Altaromin
  • United Kingdom (Northern Ireland) · Hiprex, Methenamine Hippurate Brown & Burk Uk
  • Iceland · Haiprex
  • Luxembourg · Vesaphir
  • Malta · Methenamine Hippurate Brown & Burk, Methenamine Hippurate Eql Pharma
  • Netherlands · Vesaphir
  • Norway · Hiprex, Methenamine Hippurate Eql Pharma
  • Sweden · Hiprex, Methenamine Hippurate Brown & Burk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bd2ed15a-a94e-4f13-b3ee-0c2593e3f41b
GET /v1/drugs/bd2ed15a-a94e-4f13-b3ee-0c2593e3f41b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "J01XX05"
  ],
  "strength": null,
  "pa_number": "PA23148/010/001",
  "substances": [
    "Methenamine hippurate"
  ],
  "legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
  "market_info": "Not marketed",
  "authorised_at": "06/07/2026",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about methenamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.